T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Palo Alto Networks
PANW
$315B
| $799M | 0.09% |
4,337,468
-214,562
| -5% | -$43.3M |
|
177
Canadian National Railway
CNI
$76.4B
| $794M | 0.09% |
8,032,989
+89,972
| +1% | +$8.65M |
|
178
MongoDB
MDB
$35.2B
| $783M | 0.08% |
1,864,795
-88,290
| -5% | -$32.1M |
|
179
Corpay
CPAY
$26.9B
| $780M | 0.08% |
2,593,136
-1,230,266
| -32% | -$357M |
|
180
Uranium Energy
UEC
$5.62B
| $775M | 0.08% |
66,352,123
+7,013,279
| +12% | +$92M |
|
181
Pentair
PNR
$10.5B
| $774M | 0.08% |
7,433,157
-195,064
| -3% | -$20.8M |
|
182
Roper Technologies
ROP
$39.1B
| $772M | 0.08% |
1,733,491
-1,337,272
| -44% | -$619M |
|
183
Union Pacific
UNP
$174B
| $764M | 0.08% |
3,301,151
-407,886
| -11% | -$93.1M |
|
184
APi Group
APG
$18.8B
| $763M | 0.08% |
19,951,282
-71,605
| -0.4% | -$2.65M |
|
185
Public Storage
PSA
$60.4B
| $757M | 0.08% |
2,916,469
-433,598
| -13% | -$121M |
|
186
Repligen
RGEN
$9.35B
| $754M | 0.08% |
4,599,061
+1,091,683
| +31% | +$171M |
|
187
S&P Global
SPGI
$121B
| $752M | 0.08% |
1,438,354
-732,419
| -34% | -$362M |
|
188
Huntington Bancshares
HBAN
$36.1B
| $747M | 0.08% |
43,053,306
-20,387,914
| -32% | -$335M |
|
189
Western Alliance Bancorporation
WAL
$9.01B
| $735M | 0.08% |
8,746,867
+777,369
| +10% | +$63.1M |
|
190
Stanley Black & Decker
SWK
$15.5B
| $735M | 0.08% |
9,898,190
+101,769
| +1% | +$7.17M |
|
191
Freeport-McMoran
FCX
$96.9B
| $732M | 0.08% |
14,415,517
-2,918,065
| -17% | -$126M |
|
192
T. Rowe Price Capital Appreciation Equity ETF
TCAF
$8.31B
| $730M | 0.08% |
19,069,107
+1,799,525
| +10% | +$68.9M |
|
193
Pinterest
PINS
$13B
| $720M | 0.08% |
27,809,693
+3,669,476
| +15% | +$106M |
|
194
AvalonBay Communities
AVB
$25.7B
| $713M | 0.08% |
3,934,153
-167,260
| -4% | -$30.4M |
|
195
Nu Holdings
NU
$65.5B
| $713M | 0.08% |
42,602,086
+4,215,824
| +11% | +$67.8M |
|
196
Boston Scientific
BSX
$74.5B
| $711M | 0.08% |
7,457,286
-920,040
| -11% | -$90.2M |
|
197
Ventas
VTR
$45.7B
| $710M | 0.08% |
9,176,254
+2,000,341
| +28% | +$151M |
|
198
Southwest Airlines
LUV
$22B
| $709M | 0.08% |
17,165,941
-1,410,222
| -8% | -$49.3M |
|
199
InterDigital
IDCC
$9.07B
| $707M | 0.08% |
2,222,111
+854,845
| +63% | +$302M |
|
200
Corning
GLW
$144B
| $704M | 0.08% |
8,034,856
-1,249,300
| -13% | -$108M |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.